Effects of Total Thyroid Removal on Parathyroid Function and Quality of Life
Key facts
- Who runs it
- Aarhus University Hospital
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 150 people, planned
- Started
- 1 Jan 2026
- Expected to end
- Dec 2028
- Type of study
- Interventional, 4 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- high-dose calcium (400 mg x 4), vitamin D (19 mikg x 4), and active vitamin D supplementation (2 mikg x 2)
- Ommit routine blood test post operative day 1
- Record updated
- 2 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (5)Hide the full registry criteria
Who can take part
- Adult patients (≥18 years) undergoing Total thyroidectomy with intraoperative PTH measurements
Who cannot take part
- Malabsorption (intestinal resection or gastric by-pass)
- Previous thyroid or parathyroid operations
- Renal insufficiency (eGFR<30 ml/min) or deemed clinically high-risk requiring mandatory biochemical monitoring
- Hypercalcemia (Ca2+ > 1.32 mmol/L)
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Hypoparathyroidism post-surgical or quality of life
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Postoperative hypoparathyroidism (hypoPT) is the most frequent complication after total thyroidectomy (TT). It is caused by impaired parathyroid function, leading to low calcium levels, patient discomfort, reduced quality of life (QoL), and increased healthcare costs. Traditionally, all TT patients undergo routine postoperative blood testing and standard calcium supplementation, despite varying individual risk.
Read full original descriptionShow less
This investigator-initiated project aims to improve patient outcomes by using intraoperative parathyroid hormone (ioPTH) measurements to guide postoperative care. The ioPTH decline reflect parathyroid function immediately after surgery and can identify patients at high or low risk of hypoPT.
The study is designed as a prospective, randomized controlled trial (RCT) with two arms:
Arm A (<75% ioPTH decrease): Patients randomized to either omission of routine postoperative calcium/PTH blood tests or standard monitoring.
Arm B (>75% ioPTH decrease): Patients randomized to either early high-dose calcium and vitamin D supplementation or standard therapy.
Primary outcomes are calcium and PTH levels postoperatively, incidence of hypocalcemia, and healthcare resource use. Secondary outcomes include QoL assessed by validated questionnaires (ThyPro39, SF-36, HPQ27), transient and permanent hypoPT rates, and other surgical complications.
By tailoring care to individual risk, the study aims to safely reduce unnecessary blood tests and optimize early treatment for high-risk patients. This approach has the potential to shorten hospital stays, reduce symptoms, improve QoL, and lower costs. The findings may influence clinical guidelines nationally and internationally, supporting more personalized and evidence-based management of TT patients.
The 4 groups in the trial
- <75 % fall in intraoperative parathyroidhormoneNo study treatment, for comparison
Standard blood test on post operative day 1 including PTH and P-ca
- <75 % fall in intraoperative parathyroidhormone experimentalTreatment being tested
Ommit routine blood test on post operative day 1
Treatment: Ommit routine blood test post operative day 1
- >75% fall in intraoperative parathyroidhormoneNo study treatment, for comparison
Standard treatment
- >75% fall in intraoperative parathyroidhormone experimentalTreatment being tested
Start in Unikalk 4 times per day + d-vitamin + alfacalcidol 2 microgram 2 times per day.
Treatment: high-dose calcium (400 mg x 4), vitamin D (19 mikg x 4), and active vitamin D supplementation (2 mikg x 2)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Impact of Total Thyroidectomy on Parathyroid Function and Quality of Life
- Criteria questions
- Built from NCT07381998, who can take part
- Record updated
- 2 February 2026